Pharma Journalist -

BioXcel Therapeutics, a clinical-stage biopharmaceutical development company utilizing novel artificial intelligence approaches to identify and advance the next wave of medicines in…
Read More...

BioQ Pharma Incorporated, a specialty pharmaceutical company, today announced that it has entered into a Development, Supply, Distribution Agreement with Avanos Medical. Under the…
Read More...

iBio, Inc. announced that it has entered into the initial Statement of Work under its Memorandum of Understanding with AzarGen Biotechnologies (Pty.) Ltd. Following iBio’s successful…
Read More...

POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH),…
Read More...

Concert Pharmaceuticals announced that it has completed patient enrollment of an open label clinical trial to evaluate once-daily 24 mg compared to twice-daily 12 mg oral dosing of…
Read More...

Novartis, a leader reimagining rheumatology and immuno-dermatology, announced positive new data from the PREVENT trial evaluating the efficacy and safety of Cosentyx (secukinumab) in…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted…
Read More...

Merck, known as MSD outside the United States and Canada, and Eisai announced that the U.S. Food and Drug Administration (FDA) approved the combination of KEYTRUDA, Merck’s anti-PD-1…
Read More...

SMi Reports: Exclusive interview with industry expert from Novartis, 3 weeks ahead of the inaugural Wearable Injectors and Connected Devices conference 2019 The Wearable Injectors…
Read More...

AlivaMab Discovery Services, a company providing custom human therapeutic antibody drug discovery services using the AlivaMab Mouse, a best-in-class antibody discovery platform,…
Read More...